본문 바로가기
KERD
논문KCI 등재

A Case of Catatonia and Neuroleptic Malignant Syndrome Probably Associated with Antipsychotic in Korea

구본훈|Ho-Dong Choi|Kyoung-Keun Kim
대한신경정신의학회 (Korean Neuropsychiatric Association)|2011.06|PSYCHIATRY INVESTIGATION|제8권 제2호|pp. 174-177

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Atypical antipsychoticsCatatoniaNeuroleptic malignant syndrome.
주제분류정신과학

초록

Several studies have reported on catatonia caused by the use of antipsychotic drugs and on the association between catatonia and neuroleptic malignant syndrome (NMS), but none has reported such a case in Korea. Here, we report the case of a 20-year-old woman whose catatonia and NMS appeared associated with the administration of an atypical antipsychotic drug. We discuss the association between NMS and catatonia due to neuroleptic use.

Abstract

Several studies have reported on catatonia caused by the use of antipsychotic drugs and on the association between catatonia and neuroleptic malignant syndrome (NMS), but none has reported such a case in Korea. Here, we report the case of a 20-year-old woman whose catatonia and NMS appeared associated with the administration of an atypical antipsychotic drug. We discuss the association between NMS and catatonia due to neuroleptic use.

참고문헌 (36)

  1. Fink M, "Treating neuroleptic malignant syndrome as catatonia", J Clin Psychopharmacol, 21, pp.121~122 (2001)
  2. Paparrigopoulos T, "Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine", World J Biol Psychiatry, 10, pp.70~73 (2009)
  3. Peralta V, "The Kahlbaum syndrome: a study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder", Compr Psychiatry, 38, pp.61~67 (1997)
  4. Northoff G, "What catatonia can tell us about “top-down modulation”: a neuropsychiatric hypothesis", Behav Brain Sci, 25, pp.555~577 (2002)
  5. Caroff SN, "Neuroleptic malignant syndrome", Med Clin North Am, 77, pp.185~202 (1993)
  6. Hasan S, "Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique", Am J Psychiatry, 155, pp.1113~1116 (1998)
  7. Mann SC, "Central dopamine hypoactivity and the pathogenesis of the neuroleptic malignant syndrome", Psychiatr Ann, 30, pp.363~374 (2000)
  8. White DA, "Catatonia and the neuroleptic malignant syndrome--a single entity", Br J Psychiatry, 161, pp.558~560 (1992)
  9. White DA, "Catatonia: harbinger of the neuroleptic malignant syndrome", Br J Psychiatry, 158, pp.419~421 (1991)
  10. Raja M, "Neuroleptic malignant syndrome and catatonia. A report of three cases", Eur Arch Psychiatry Clin Neurosci, 243, pp.299~303 (1994)
  11. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2000), American Psychiatric Press
  12. Dhossche DM, "Is there a Common Neuronal Basis for Autism and Catatonia?, in Catatonia in Autism Spectrum Disorders", pp.2006, Elsevier
  13. Woodbury MM, "Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome", J Am Acad Child Adolesc Psychiatry, 31, pp.1161~1164 (1992)
  14. Tsai JH, "Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome", Pharmacotherapy, 25, pp.1156~1159 (2005)
  15. Chakraborty N, "Aripiprazole and neuroleptic malignant syndrome", Int Clin Psychopharmacol, 19, pp.351~353 (2004)
  16. Leibold J, "Neuroleptic malignant syndrome associated with ziprasidone in an adolescent", Clin Ther, 26, pp.1105~1108 (2004)
  17. Zalsman G, "Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents", Int J Adolesc Med Health, 16, pp.179~182 (2004)
  18. Dew RE, "Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome", Int J Adolesc Med Health, 17, pp.187~188 (2005)
  19. Kobayashi A, "Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.1170~1172 (2006)
  20. Norgard NB, "Olanzapine-associated neuroleptic malignant syndrome", Pharmacotherapy, 26, pp.1180~1182 (2006)
  21. Nopoulos P, "Atypical neuroleptic malignant syndrome (NMS) with an atypical neuroleptic: clozapine-induced NMS without rigidity", Ann Clin Psychiatry, 2, pp.251~253 (1990)
  22. Lee JW, "Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome", Ann Clin Psychiatry, 19, pp.9~16 (2007)
  23. Fink M, "Neuroleptic malignant syndrome and catatonia: one entity or two", Biol Psychiatry, 39, pp.1~4 (1996)
  24. Carroll BT, "The nondichotomy between lethal catatonia and neuroleptic malignant syndrome", J Clin Psychopharmacol, 17, pp.235~238 (1997)
  25. Carroll BT, "Serum iron in catatonia", Biol Psychiatry, 38, pp.776~777 (1995)
  26. Nisijima K, "Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome", J Psychiatr Res, 29, pp.233~ (1995), 244
  27. Northoff G, "Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients", Psychol Med, 26, pp.547~553 (1996)
  28. Northoff G, "Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia", Schizophr Res, 44, pp.193~211 (2000)
  29. Lew TY, "Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam", Biol Psychiatry, 18, pp.1441~1446 (1983)
  30. Kontaxakis VP, "Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam", Acta Psychiatr Scand, 78, pp.396~398 (1988)
  31. Miyaoka H, "Diazepam- responsive neuroleptic malignant syndrome: a diagnostic subtype", Am J Psychiatry, 154, pp.882~ (1997)
  32. Koch M, "Catatonic signs in neuroleptic malignant syndrome", Compr Psychiatry, 41, pp.73~75 (2000)
  33. Addonizio G, "Neuroleptic malignant syndrome: review and analysis of 115 cases", Biol Psychiatry, 22, pp.1004~1020 (1987)
  34. Mathews T, "Proposed research diagnostic criteria for neuroleptic malignant syndrome", Int J Neuropsychopharmacol, 2, pp.129~144 (1999)
  35. Carroll BT, "Catatonia is a risk factor for neuroleptic malignant syndrome", J Clin Psychiatry, 65, pp.1722~1723 (2004)
  36. Malur C, "ECT for prolonged catatonia", J ECT, 17, pp.55~59 (2001)

관련 논문AI추천

비정형 항정신병약물 사용과 신경이완제 악성 증후군: 임상적 관점 기반 종설김가영대한조현병학회 · 대한조현병학회지2024 · 제27권 제2호장기간 할로페리돌을 복용한 환자에게 나타난 신경이완제악성증후군장혁, 김요식, 박수신, 박현영, 박형종, 이학승, 조광호, 조재훈, 하연수대한신경과학회 · 대한신경과학회지2011 · 제29권 제3호A Neuroleptic Malignant Syndrome Without RigidityErkan Kuru, İlker Özdemir, Rıza Gökçer Tulacı, Yasir Safak대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제2호항정신병약물성 악성증후군 2례김성욱, 김희철, 박영남대한생물치료정신의학회 · 생물치료정신의학1995 · 제1권 제2호Risperidone에서 Clozapine으로 교체 도중 발생한 비정형 신경이완제 악성 증후군 1예박영민, 이덕기, 최진환대한생물치료정신의학회 · 생물치료정신의학2007 · 제13권 제1호Clozapine Induced Neuroleptic Malignant Syndrome신정훈, 오국환, 유병철, 조용숙, 조형아대한중환자의학회 · Acute and Critical Care2017 · 제32권 제3호

이 간행물의 다른 논문 (6건)

Schizophrenia, Cancer and Obstetric Complications in an Evolutionary Perspective-An Empirically Based HypothesisDaniel R. Wilson, Antonio Pretipp. 77-88A Comparison of Comorbidity and Psychological Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderMisun Song, Yoon Huh, Inchul Choi, 홍성도, 정유숙, Sunyoung Kimpp. 95-101Relationship between Personality and Insomnia in Panic Disorder Patients이상열, 김의정, 유범희, 이승환, 강은호, 나혜란, 우종민, 정상근, 김율리pp. 102-106Serum Homocysteine and Folate Levels in Korean Schizophrenic Patients문석우, Tae Ho Kimpp. 134-140The Changes of Blood Glucose Control and Lipid Profiles after Short-Term Smoking Cessation in Healthy Males백인호, 이희진, 채숙희, 채정호, 김대진, 이철, 서정석, 이창욱, 이주열, 김성래, 남범우, 원왕연, 정조은, 유순집, 이성수pp. 149-154
원문 보기